Biologically Inspired Engineering, synbio, synthetic biology, crispr
The PC gaming market inflected upwards in 1999, sparking the geometric growth of parallel processing computer chips designed to optimize gaming. More recently, GPU deep learning ignited modern AI — the next era of computing — with the GPU acting as the brain of computers, robots, and self-driving cars that can perceive and understand the … Read more
Synthetic biology starts and ends with data, and it’s no secret that the human immune system is migrating to the cloud. Cleveland Clinic and IBM have announced a planned 10-year partnership to establish the Discovery Accelerator, a joint Cleveland Clinic – IBM center with the mission of fundamentally advancing the pace of discovery in healthcare and … Read more
Nautilus Biotechnology, Inc., a company pioneering a single-molecule protein analysis platform for quantifying the human proteome, and Arya Sciences Acquisition Corp III, a special purpose acquisition company or SPAC, sponsored by Perceptive Advisors, announced in February a definitive business combination agreement. The combined company is expected to receive proceeds of approximately $350 million at the closing … Read more
Many things must work together at many different levels – from organs to cells to genes – for your body to develop properly and stay healthy. From both inside and outside the body, cells are constantly receiving chemical cues prompted by such things as injury, infection, stress or even the presence or lack of food. … Read more
Biosensing is the main component of the future personal area network. The Apple Watch is the most widely known biosensing device. The latest version (Series 6, released September 2020) sparkles with features that lean perpetually towards health including a class II FDA clearance for electrocardiogram for atrial fibrillation (AFib) detection and wellness-grade daily blood oxygen … Read more
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has awarded $2.5 million in grants to 12 institutes around the world to support research on bacteriophage therapy. These awards represent NIAID’s first series of grants focused exclusively on research on this therapy, an emerging field that could yield … Read more
In February, Quantum-Si Incorporated, a pioneer in next generation semiconductor chip-based proteomics, and HighCape Capital Acquisition Corp., a special purpose acquisition company sponsored by HighCape Capital LP, announced a business combination agreement. Upon completion of the transaction, the combined company’s Class A common stock is expected to be traded on The Nasdaq Stock Market (“Nasdaq”) … Read more
Founded in 2018, Biotheus is a Zhuhai, China-based clinical development stage company with the mission of treating cancer and autoimmune diseases through next-generation therapeutics. The company’s product pipeline consists of over ten novel monoclonal and multispecific antibodies focused on curing malignant tumors and autoimmune diseases. Biotheus currently has two bispecific antibodies in phase I clinical … Read more
Since taking office in January, President Joe Biden has reaffirmed a national commitment to integrity in scholarship and research, appointing scientists to numerous leadership roles. Educators and experts applaud these appointments and say elevating intellectual integrity in research and science will take the combined effort of universities, industry and the public, too. Biden appointed Eric … Read more
Infinitus is a voice robotic process automation (VoiceRPA) company that is targeting the complexity and cost in U.S. healthcare. Another player in the healthcare robotic process automation (RPA) arena just completed a large capital raise. These RPA companies are bringing enterprise cloud/SaaS dynamism towards a much-needed re-platforming of the ailing and inefficient U.S. healthcare industry. … Read more